HDAC3
Histone deacetylase 3
Also known as: HD3, HDAC3_HUMAN, KDAC3, RPD3, RPD3-2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O15379
- Gene
- HDAC3
- Ensembl
- ENSG00000171720
- Chromosome
- 5
- Canonical length
- 428 aa
- Protein class
- Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus
OverviewNCBI Gene
Histones play a critical role in transcriptional regulation, cell cycle progression, and developmental events. Histone acetylation/deacetylation alters chromosome structure and affects transcription factor access to DNA. The protein encoded by this gene belongs to the histone deacetylase/acuc/apha family. It has histone deacetylase activity and represses transcription when tethered to a promoter. It may participate in the regulation of transcription through its binding with the zinc-finger transcription factor YY1. This protein can also down-regulate p53 function and thus modulate cell growth and apoptosis. This gene is regarded as a potential tumor suppressor gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
428 residues, UniProt reviewed canonical sequence.
>O15379|HDAC3
1 MAKTVAYFYD PDVGNFHYGA GHPMKPHRLA LTHSLVLHYG LYKKMIVFKP YQASQHDMCR
61 FHSEDYIDFL QRVSPTNMQG FTKSLNAFNV GDDCPVFPGL FEFCSRYTGA SLQGATQLNN
121 KICDIAINWA GGLHHAKKFE ASGFCYVNDI VIGILELLKY HPRVLYIDID IHHGDGVQEA
181 FYLTDRVMTV SFHKYGNYFF PGTGDMYEVG AESGRYYCLN VPLRDGIDDQ SYKHLFQPVI
241 NQVVDFYQPT CIVLQCGADS LGCDRLGCFN LSIRGHGECV EYVKSFNIPL LVLGGGGYTV
301 RNVARCWTYE TSLLVEEAIS EELPYSEYFE YFAPDFTLHP DVSTRIENQN SRQYLDQIRQ
361 TIFENLKMLN HAPSVQIHDV PADLLTYDRT DEADAEERGP EENYSRPEAP NEFYDGDHDN
421 DKESDVEILocalizationUniProt · AlphaFold · HPA
Whether an antibody against HDAC3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 42 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 42 nTPM
- tonsil: 40 nTPM
- skin: 40 nTPM
- skeletal muscle: 39 nTPM
- adrenal gland: 39 nTPM
- liver: 37 nTPM
Single-cell type
- esophageal apical cells: 87 nCPM
- adrenal cortex cells: 81 nCPM
- esophageal basal cells: 79 nCPM
- esophageal suprabasal cells: 77 nCPM
- syncytiotrophoblasts: 76 nCPM
- suprabasal keratinocytes: 75 nCPM
Immune cell
- myeloid DC: 108 nTPM
- T-reg: 56 nTPM
- plasmacytoid DC: 55 nTPM
- intermediate monocyte: 54 nTPM
- classical monocyte: 52 nTPM
- memory B-cell: 48 nTPM
Brain region
- choroid plexus: 13 nTPM
- cerebral cortex: 10 nTPM
- thalamus: 10 nTPM
- spinal cord: 10 nTPM
- hypothalamus: 10 nTPM
- medulla oblongata: 9.8 nTPM
ReferencesPubMed · IEDB
Publications for HDAC3 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
1 publication
- Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis.
2009 · Autoimmunity · RCR 0.2 · 11 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.41
- gnomAD pLI
- 0.57
- gnomAD missense Z
- 3.72
- DepMap mean gene effect
- -0.93
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to fluid shear stress
- cellular response to mechanical stimulus
- cellular response to parathyroid hormone stimulus
- chromatin organization
- circadian regulation of gene expression
- cornified envelope assembly
- DNA repair-dependent chromatin remodeling
- epigenetic regulation of gene expression
- establishment of mitotic spindle orientation
- establishment of skin barrier
- in utero embryonic development
- negative regulation of apoptotic process
- negative regulation of cardiac muscle cell differentiation
- negative regulation of DNA-templated transcription
- negative regulation of interleukin-1 production
- negative regulation of JNK cascade
- negative regulation of protein export from nucleus
- negative regulation of transcription by RNA polymerase II
- negative regulation of tumor necrosis factor production
- neural precursor cell proliferation
- positive regulation of cold-induced thermogenesis
- positive regulation of ferroptosis
- positive regulation of neuron apoptotic process
- positive regulation of protein import into nucleus
- positive regulation of protein phosphorylation
- positive regulation of protein ubiquitination
- positive regulation of TOR signaling
- positive regulation of transcription by RNA polymerase II
- positive regulation of type B pancreatic cell apoptotic process
- protein deacetylation
- random inactivation of X chromosome
- regulation of circadian rhythm
- regulation of mitotic cell cycle
- regulation of multicellular organism growth
- regulation of protein stability
- response to dexamethasone
- response to nutrient levels
- response to xenobiotic stimulus
- spindle assembly
- transcription by RNA polymerase II
Molecular functions
- chromatin binding
- chromatin DNA binding
- cyclin binding
- DNA-binding transcription factor binding
- enzyme binding
- GTPase binding
- histone deacetylase activity
- histone deacetylase activity, hydrolytic mechanism
- histone deacetylase binding
- histone decrotonylase activity
- NF-kappaB binding
- protein de-2-hydroxyisobutyrylase activity
- protein lysine deacetylase activity
- protein lysine delactylase activity
- transcription corepressor activity
- transcription corepressor binding
- ubiquitin-specific protease binding
- histone isonicotinyllysine deisonicotinylase activity
- protein decrotonylase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HDAC3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HDAC3 as an antibody target. Whether an autoantibody or antibody against HDAC3 could matter depends on whether native HDAC3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HDAC3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HDAC3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...